ES2062220T3 - 4-(amino n-sustituido)-2-butinil-1-ureas y tioureas y derivados de las mismas de utilidad como agentes muscarinicos de actuacion central. - Google Patents

4-(amino n-sustituido)-2-butinil-1-ureas y tioureas y derivados de las mismas de utilidad como agentes muscarinicos de actuacion central.

Info

Publication number
ES2062220T3
ES2062220T3 ES90114787T ES90114787T ES2062220T3 ES 2062220 T3 ES2062220 T3 ES 2062220T3 ES 90114787 T ES90114787 T ES 90114787T ES 90114787 T ES90114787 T ES 90114787T ES 2062220 T3 ES2062220 T3 ES 2062220T3
Authority
ES
Spain
Prior art keywords
thioureas
ureas
derivatives
hunting
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90114787T
Other languages
English (en)
Inventor
Jeffrey Alan Kester
Anthony Jerome Thomas
Walter Hamilton Moos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of ES2062220T3 publication Critical patent/ES2062220T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/02—Thiourea
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

SON DESCRITAS UREAS-1-BUTINIL-2-(AMINO SUSTITUIDO-N)-4 Y TIOUREAS Y SUS DERIVADOS, COMO TAMBIEN METODOS PARA LA PREPARACION Y COMPOSICIONES FARMACEUTICAS DEL MISMO; QUE SON UTILES COMO AGENTES MUSCARINICOS QUE ACTUAN CENTRALMENTE Y SON UTILES COMO AGENTES ANALGESICOS PARA EL TRATAMIENTO DEL DOLOR, COMO AYUDA DE DORMIR Y COMO AGENTES PARA TRATAR LOS SINTOMAS DE LA DEMENCIA SENIL, MAL DE ALZHEIMER, COREA DE HUNTINGTON, DISQUINESIA TARDIVA, HIPERQUINESIA, MANIA, O CONDICIONES SIMILARES DE LA INSUFICIENCIA CEREBRAL CARACTERIZADA POR LA PRODUCCION DE ACETILCOLINA CEREBRAL DISMINUIDA O LIBRE.
ES90114787T 1989-08-02 1990-08-01 4-(amino n-sustituido)-2-butinil-1-ureas y tioureas y derivados de las mismas de utilidad como agentes muscarinicos de actuacion central. Expired - Lifetime ES2062220T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/388,785 US4988688A (en) 1989-08-02 1989-08-02 4-(N-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents

Publications (1)

Publication Number Publication Date
ES2062220T3 true ES2062220T3 (es) 1994-12-16

Family

ID=23535507

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90114787T Expired - Lifetime ES2062220T3 (es) 1989-08-02 1990-08-01 4-(amino n-sustituido)-2-butinil-1-ureas y tioureas y derivados de las mismas de utilidad como agentes muscarinicos de actuacion central.

Country Status (15)

Country Link
US (1) US4988688A (es)
EP (1) EP0411615B1 (es)
JP (1) JPH0374359A (es)
KR (1) KR910004559A (es)
AT (1) ATE99290T1 (es)
AU (1) AU6001990A (es)
CA (1) CA2022510A1 (es)
DE (1) DE69005557T2 (es)
DK (1) DK0411615T3 (es)
ES (1) ES2062220T3 (es)
FI (1) FI903835A7 (es)
IE (1) IE902792A1 (es)
NO (1) NO903384L (es)
PT (1) PT94874A (es)
ZA (1) ZA906057B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09504278A (ja) * 1944-06-01 1997-04-28 ザ、ウェルカム、ファンデーション、リミテッド Ｎｏシンターゼインヒビターとしての置換尿素およびイソチオ尿素誘導体
US5202459A (en) * 1989-11-07 1993-04-13 Nippon Kayaku Kabushiki Kaisha Process for producing cyclobutane derivative
US5182284A (en) * 1990-01-26 1993-01-26 Taiho Pharmaceutical Co., Ltd. Piperazine compounds, processes for preparation thereof and medical uses thereof
FR2677019B1 (fr) * 1991-05-27 1994-11-25 Pf Medicament Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
US6297276B1 (en) 1993-10-04 2001-10-02 Glaxosmithkline Substituted urea and isothiourea derivatives as no synthase inhibitors
US6090846A (en) * 1994-06-01 2000-07-18 Glaxo Wellcome Inc. Substituted urea and isothiourea derivatives as no synthase inhibitors
US6225305B1 (en) 1993-10-04 2001-05-01 Glaxo Wellcome Inc. Substituted urea and isothiorea derivatives as no synthase inhibitors
GB9418912D0 (en) * 1994-09-20 1994-11-09 Fisons Corp Pharmaceutically active compounds
TW397812B (en) * 1995-02-11 2000-07-11 Astra Ab Bicyclic isothiourea derivatives useful in therapy
US6545182B2 (en) * 2000-04-13 2003-04-08 Allergan Sales, Inc. Methods and compositions for modulating alpha adrenergic receptor activity
US6313172B1 (en) * 2000-04-13 2001-11-06 Allergan Sales, Inc. Methods and compositions for modulating alpha adrenergic receptor activity
US7185522B2 (en) 2005-05-10 2007-03-06 T. Sendzimir, Inc. Side supported 6-high rolling mill

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065471A (en) * 1965-04-09 1977-12-27 Sterling Drug Inc. N-(4-Amino-2-butynyl)imides
US3354178A (en) * 1965-04-09 1967-11-21 Sterling Drug Inc Nu-(4-amino-2-butynyl)-nu-alkylcarboxamides

Also Published As

Publication number Publication date
DE69005557D1 (de) 1994-02-10
JPH0374359A (ja) 1991-03-28
DK0411615T3 (da) 1994-01-24
NO903384D0 (no) 1990-08-01
DE69005557T2 (de) 1994-04-21
ATE99290T1 (de) 1994-01-15
NO903384L (no) 1991-02-04
KR910004559A (ko) 1991-03-28
FI903835A0 (fi) 1990-08-01
CA2022510A1 (en) 1991-02-03
US4988688A (en) 1991-01-29
FI903835A7 (fi) 1991-02-03
AU6001990A (en) 1991-02-07
PT94874A (pt) 1991-04-18
IE902792A1 (en) 1991-02-27
EP0411615B1 (en) 1993-12-29
ZA906057B (en) 1992-04-29
EP0411615A1 (en) 1991-02-06

Similar Documents

Publication Publication Date Title
ES2072323T3 (es) Compuestos de piperidina y su preparacion y empleo.
ES2068955T3 (es) Derivados de 1,2,3,4-tetrahidro-9-acridinamina.
ES2150567T3 (es) Antagonistas del factor de liberacion de la corticotropina.
BR0113039A (pt) Composto ou um seu sal ou solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um indivìduo humano ou animal com uma condição antiinflamatória e/ou alérgica, e, processo para preparar um composto
DE3855056D1 (de) Verfahren zur Herstellung reiner primärer Diamine
AR002289A1 (es) Derivados de acetamida, procedimiento para prepararlos, las composiciones farmaceuticas que los contienen y las aplicaciones de dichos compuestos comoansioliticos y en el tratamiento de enfermedades inmuno-inflamatorias.
MX9205681A (es) Aminometil-cromanos, procedimiento para su fabricacion y medicamento que los contiene.
DE69004837D1 (de) Verwendung von 5-Methyltetrahydrofolsäure, 5-Formyltetrahydrofolsäure sowie deren pharmazeutisch geeigneten Salzen zur Herstellung von Arzneimitteln mit gesteuerter Freigabe und wirksam in der Therapie organisch mentaler Störungen sowie die entsprechenden Arzneimittel.
ES2124707T3 (es) Compuestos heterociclicos y su preparacion y utilizacion.
ES2070981T3 (es) Concentrados de componente activo y nuevas combinaciones de componente activo de hojas de ginkgo biloba, sus metodos de preparacion y productos farmaceuticos que contienen los concentrados de componente activo o las combinaciones de componente activo.
FI103506B1 (fi) Menetelmä syklisten aminohappojohdannaisten valmistamiseksi ja menetelmässä käytettävä välituote
ES2054723T3 (es) Tetrahidropiridinoximas, procedimiento para su preparacion y uso de las mismas como agentes colinergicos.
BR9506292A (pt) Composto e seus sais fisiologicamente aceitáveis processo para a preparaçÃo do mesmo e composiçÃo farmacêutica
ES2065324T3 (es) N-(piridinil)-1h-indol-1-aminas, un procedimiento para su preparacion y su uso como medicamentos.
MX9202190A (es) 2-carboxiindoles substituidos que tienen actividad farmaceutica.
ES2072263T3 (es) Derivados de 4-aminopiridina.
DK0411615T3 (da) 4-(N-Substitueret amino)-2-butynyl-1-urinstoffer og -thiourinstoffer og derivater deraf som centralt virkende muscariniske midler
AR008244A1 (es) Compuestos heterociclicos, procedimiento para prepararlos, composiciones farmaceuticas que los comprenden, uso de dichos compuestos en la fabricacion de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
ES2112832T3 (es) Derivados carbamoilicos.
IT1164387B (it) Derivati n-sostituiti dell'1-(4'-alchilsulfonilfenil)-2-ammino-1,3-propandiolo
ES2052901T3 (es) Un metodo para preparar derivados e isomeros de 4,5,6,7-tetrahidroisotiazolo(4,5-c)piridinas.
DK249288A (da) Substituerede silylalkylenaminer og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
IT1230140B (it) Derivati della serina, loro processo di preparazione e impiego in terapia umana
IT1164389B (it) Derivati n-sostituiti dell'1-(4'-alchiltiofenil)-2-ammino-1,3-propandiolo
ATE131043T1 (de) Arzneimittel enthaltend eine kombination von azt und amantadin für die behandlung von aids.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 411615

Country of ref document: ES